Skip to main content

Headline Roundup July 27th, 2020

Moderna, NIH Advance Coronavirus Vaccine Trials

Summary from the AllSides News Team

In partnership with the National Institutes of Health, biotechnology company Moderna plans to enroll roughly 30,000 subjects in Phase 3 of its COVID-19 coronavirus vaccine trial. The Biomedical Advanced Research and Development Authority have awarded Moderna another $472 million to fill the gap in needed funds. This brings the company's U.S.-based financial backing to roughly $955 million. Reporting on the matter has been consistent regardless of media bias ratings or purported political leanings.

Featured Coverage of this Story

Late-stage clinical trial for Moderna’s COVID-19 vaccine is launched at Brigham and Women’s
Late-stage clinical trial for Moderna’s COVID-19 vaccine is launched at Brigham and Women’s

The Boston Globe

News

A nationwide study begins Monday to find out if a potential coronavirus vaccine, developed by Cambridge-based Moderna and the National Institute of Allergy and Infectious Diseases, is safe and effective in preventing people from getting COVID-19.

The clinical trial will enroll 30,000 people, with Brigham and Women’s Hospital leading the New England section of the trial.

The Moderna vaccine is one of five candidates that have advanced to Phase 3, the stage of research in which large numbers of people get either the vaccine or a placebo and are then...

Open on The Boston Globe
How to volunteer for a coronavirus vaccine trial
How to volunteer for a coronavirus vaccine trial

CNET

News

If you're actively searching for a way to constructively contribute to the resolution of the coronavirus pandemic, you could consider volunteering for a coronavirus vaccine study. By taking part in a vaccine trial, you'd be a major player in moving science forward so the world can finally get a grip on the virus that's been overloading hospitals, taking lives and forcing lockdowns for more than six months now.

With more than 10 million cases worldwide and more than half a million deaths, it's clear that we need an intervention. If...

Open on CNET
Moderna Funding Nears $1 Billion as Vaccine Study Starts
Moderna Funding Nears $1 Billion as Vaccine Study Starts

Newsmax (News)

News

Moderna Inc. climbed as much as 11% Monday after getting a second round of U.S. funding for an experimental vaccine for COVID-19 and kicking off its late-stage trial.

With an additional $472 million award from the Biomedical Advanced Research and Development Authority (BARDA) announced on Sunday, Moderna’s shot is now backed by $955 million of funds from the U.S.

The first participants in the 30,000 person study have been dosed, the Cambridge, Mass-based biotech company said on Monday. Earlier, it said that the new award closed a funding gap in...

Open on Newsmax (News)

More headline roundups

More News about Coronavirus on AllSides

News from the Left

News from the Center

News from the Right